The exports of our proprietary chinese medicine accounted only 0.5% in the eu market
|
With the traditional plant herb medicine (eu), registered program instruction "seven years to transition deadline, Chinese medicine enterprise wants to further expand the eu market, appear walking difficult.
According to the regulation, from April 30, 2004 up until 2011 during April, has listed the eu members of traditional herbal medicine sales thereafter may continue to sales, according to the provisions of the instructions must be registered rear can sale program.
The European Union is the world's largest plant medicine market, accounts for about one of the world's plant medicine market share 40%, try to attract a lot of Chinese medicine enterprises. But seven years, China is not a traditional Chinese medicine enterprise in the eu, breaking zero record is registered successfully. Facing the eu Settings "high threshold," more than a enterprise in the final stage whether sprint success, is still unknown.
Health care products import and export Chambers of commerce, vice President of liu zhang Lin when accepting a reporter to interview in the European Union, said Chinese medicine registration date must have more than 30 years in the European Union, the medicinal history at least 15 years of use history. Since most of the traditional Chinese medicine with dietary supplements, health care products, etc "identity" entering the eu market, so, a lot of Chinese medicine enterprise cannot for a kind of products to achieve sales proof. The eu has now can provide in 15 years of traditional Chinese medicine using historical proof only about 100 kinds.
In addition, the reporter understands, Chinese traditional medicine enterprise wants to get registered qualification in the eu market, still need to face high cost.
A personage inside course of study tells a reporter, according to the provisions of the European Union, a single proprietary registered the registered cost about 100 thousand yuan, and a Chinese medicine enterprises generally have many variety, plus later GMP (GMP) certification such as commissions and hardware investment, will be a large cost spending.
"This with domestic most Chinese medicine enterprises is not consistent with market performance, coupled with the recent Chinese herbal medicine frequently price hikes, enterprise stressful." Pharmaceutical industry analysts ZhaoBing said.
Pharmaceutical industry researcher GuoFan ritual also pointed out that Chinese medicine enterprise besides must deal with these "hard" attributes, still need to face and overcome some "RuanZhiBiao", such as international cultural differences, local residents in Chinese medical effect recognition and acceptance, etc.
In fact, the eu is not the main market in China, proprietary Chinese medicine exports to the European Union in China in 2010 is about 1000 Chinese exports than million us dollars, accounting for only 0.5%. However, Chinese traditional medicine enterprise in the eu market, but again the embarrassment met with Chinese enterprises and their product reflects in international disadvantaged.
"Long-term since, our country proprietary Chinese medicine to foreigners due to inability to often show its components and pharmacological activities and rejected, plus domestic GMP yet and the international community, makes the enterprise PinZao barriers in going out of." GuoFan ritual said.
Shanghai traditional Chinese medical science and technology industry promotion center promoting LiJiZong also said minister to the eu market, although our country export share is low, the "registration to make" in the short term due to the domestic Chinese medicine market influence is limited, but pharmaceutical enterprise on the road but at sea with challenges thering is no lack of pressure.
LiJiZong Suggestions, enterprise can with overseas medicine enterprises by strengthening cooperation, gradually familiar with overseas market operation procedure and characteristics, and wait until the market gradually mature, then product introduction, the effect will be better.
In addition, some experts suggest domestic pharmaceutical enterprise internal organs, stepping up to practice enhancing product quality and market competitiveness, and carefully study and analysis of the historical culture, all countries laws, the mutant.
What is worth mentioning, although the eu law of registered plant medicine products without transition period will be in by other name (such as food additives, health food, etc) in the eu market sales, but as to the present Chinese medicine health products import and export Chambers of commerce from the eu related departments to understand the circumstance looks, the eu has not yet on the strict definition and classification. |
|
Author Resource:-
I am xia zihuia professional editor from
http://www.chinacomputerparts.com/ contain a great deal of information about shawls and wraps,lambo door kit,indoor dome camera,
|
By :
Jessie Stone
Submitted
2011-04-23 04:50:21 |
Article From Article Mayhem
 Ezine ready view |
|
|
|
Related Articles
|
|
|
![[Valid RSS feed]](http://www.articlemayhem.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed![[Valid RSS feed]](http://www.articlemayhem.com/images/rss.jpg "XML Feed For RSS")